TickerFacts.

Transcode Therapeutics, Inc. (RNAZ): Cash & Equivalents

Annual figures by period end, from SEC filings.

$17.81M
As of 2025-12-31
$8.38M
As of 2026-06-30
+53.1%
3-year compound annual growth
+84.7%
5-year compound annual growth
$20.83M2020-12-31: $828.0K2021-12-31: $20.83M2022-12-31: $4.97M2023-12-31: $2.77M2024-12-31: $5.81M2025-12-31: $17.81M$17.81M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$17.81M+206.5%2026-04-15, Balance as of period end
2024-12-31$5.81M+110.0%2026-04-15, Balance as of period end
2023-12-31$2.77M-44.3%2025-04-15, Balance as of period end
2022-12-31$4.97M-76.1%2024-04-01, Balance as of period end
2021-12-31$20.83Mn/m2023-03-31, Balance as of period end
2020-12-31$828.0Kn/a2022-03-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Transcode Therapeutics, Inc. (RNAZ)2025-12-31$17.81M+206.5%
Cypherpunk Technologies Inc. (CYPH)2025-12-31$14.04M-70.3%
Apimeds Pharmaceuticals US, Inc. (APUS)2025-12-31$1.64Mn/m
Aclaris Therapeutics, Inc. (ACRS)2025-12-31$19.96M-18.8%
Gyre Therapeutics, Inc. (GYRE)2025-12-31$37.07M+213.8%
Climb Bio, Inc. (CLYM)2025-12-31$35.69M-59.1%
Boundless Bio, Inc. (BOLD)2025-12-31$17.87M-32.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)2025-12-31$28.49M+65.7%
Eledon Pharmaceuticals, Inc. (ELDN)2025-12-31$22.81M+11.0%

Compare RNAZ, CYPH, APUS, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗